Reply to: DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition

Affiliations

¹ Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² The Barer Institute, Philadelphia, PA, USA.
³ Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bgan@mdanderson.org.

Comment

Chao Mao et al. Nature. 2023 Jul.

. 2023 Jul;619(7968):E19-E23.

doi: 10.1038/s41586-023-06270-7.

¹ Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² The Barer Institute, Philadelphia, PA, USA.
³ Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bgan@mdanderson.org.

No abstract available

Comment on

DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition.
Mishima E, Nakamura T, Zheng J, Zhang W, Mourão ASD, Sennhenn P, Conrad M. Mishima E, et al. Nature. 2023 Jul;619(7968):E9-E18. doi: 10.1038/s41586-023-06269-0. Epub 2023 Jul 5. Nature. 2023. PMID: 37407687 No abstract available.

1. Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012). - DOI - PubMed - PMC
1. Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401–2421 (2022). - DOI - PubMed
1. Mao, C. et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593, 586–590 (2021). - DOI - PubMed - PMC
1. Mishima, E. et al. DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature https://doi.org/10.1038/s41586-023-06269-0 (2023).
1. Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688–692 (2019). - DOI - PubMed - PMC